Best Practices for Type 2 Diabetes Management: Update on Guidelines and New Treatment Advances

Vivian A. Fonseca, MD, FRCP, discusses best practices for the management of type 2 diabetes based on the latest guidelines and emerging treatment approaches.
Vivian A. Fonseca, MD, FRCP
Released: August 4, 2016 Expiration: No longer available for credit

Related Content

Randy Seeley, PhD: Thoughts on body weight set points and how they affect obesity and its management from Clinical Care Options (CCO)

Randy J. Seeley, PhD Released: May 4, 2021

Jenny Tong, MD, MPH, answers questions about GLP-1 receptor agonists for weight loss treatment duration and weight stability and use in patients with obesity and related comorbidities

Jenny Tong, MD, MPH Released: May 4, 2021

Steven Waguespack, MD, on hypothyroidism after immune checkpoint inhibitors, MIBG treatment, or mitotane, and the mechanism of hyperthyroidism in cancer survivors from Clinical Care Options (CCO)

Steven G. Waguespack, MD Released: April 26, 2021

Laurie Cohen, MD, on when and how to retest for GH deficiency, how soon to start GH replacement in cancer survivors from Clinical Care Options (CCO)

Laurie E. Cohen, MD Released: April 22, 2021

Acknowledgements

Jointly provided by Endocrine Society and Clinical Care Options, LLC.

For questions about content or obtaining CME credit, please contact the Endocrine Society at www.education.endocrine.org/contact.

Supported by educational grants from
Merck & Co., Inc.
Novo Nordisk Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue